AAAAAA

   
Results: 1-13 |
Results: 13
Pharmacoeconomic study of tacrolimus-based versus cyclosporine-based immunosuppressive therapy following liver transplantation
Authors: Rabkin, JM Corless, CL Rosen, HR Olyaei, AJ
Citation: Jm. Rabkin et al., Pharmacoeconomic study of tacrolimus-based versus cyclosporine-based immunosuppressive therapy following liver transplantation, TRANSPLAN P, 33(1-2), 2001, pp. 1532-1534
Prophylactic antiviral therapy in CMV high-risk liver transplant recipients
Authors: Rabkin, JM Rosen, HR Corless, CL Orloff, SL Olyaei, AJ
Citation: Jm. Rabkin et al., Prophylactic antiviral therapy in CMV high-risk liver transplant recipients, TRANSPLAN P, 33(1-2), 2001, pp. 1811-1812
Late mortality after orthotopic liver transplantation
Authors: Rabkin, JM de la Melena, V Orloff, SL Corless, CL Rosen, HR Olyaei, AJ
Citation: Jm. Rabkin et al., Late mortality after orthotopic liver transplantation, AM J SURG, 181(5), 2001, pp. 475-479
Renal toxicity of protease inhibitors
Authors: Olyaei, AJ deMattos, AM Bennett, WM
Citation: Aj. Olyaei et al., Renal toxicity of protease inhibitors, CURR OP NEP, 9(5), 2000, pp. 473-476
Nephrotoxicity of immunosuppressive drugs: Long-term consequences and challenges for the future
Authors: de Mattos, AM Olyaei, AJ Bennett, WM
Citation: Am. De Mattos et al., Nephrotoxicity of immunosuppressive drugs: Long-term consequences and challenges for the future, AM J KIDNEY, 35(2), 2000, pp. 333-346
Association of fungal infection and increased mortality in liver transplant recipients
Authors: Rabkin, JM Oroloff, SL Corless, CL Benner, KG Flora, KD Rosen, HR Olyaei, AJ
Citation: Jm. Rabkin et al., Association of fungal infection and increased mortality in liver transplant recipients, AM J SURG, 179(5), 2000, pp. 426-430
Fatal fulminant hepatitis associated with bromfenac use
Authors: Rabkin, JM Smith, MJ Orloff, SL Corless, CL Stenzel, P Olyaei, AJ
Citation: Jm. Rabkin et al., Fatal fulminant hepatitis associated with bromfenac use, ANN PHARMAC, 33(9), 1999, pp. 945-947
Immunosuppressant-induced nephropathy - Pathophysiology, incidence and management
Authors: Olyaei, AJ de Mattos, AM Bennett, WM
Citation: Aj. Olyaei et al., Immunosuppressant-induced nephropathy - Pathophysiology, incidence and management, DRUG SAFETY, 21(6), 1999, pp. 471-488
Pharmacoeconomics of immunosuppressive agents in renal transplant recipients
Authors: Bennett, WM Olyaei, AJ
Citation: Wm. Bennett et Aj. Olyaei, Pharmacoeconomics of immunosuppressive agents in renal transplant recipients, TRANSPLAN P, 31(3A), 1999, pp. 6S-6S
The impact of generic drugs on the cost of transplantation medical care
Authors: Olyaei, AJ deMattos, AM Bennett, WM
Citation: Aj. Olyaei et al., The impact of generic drugs on the cost of transplantation medical care, TRANSPLAN P, 31(3A), 1999, pp. 31S-34S
A practical guide to the management of hypertension in renal transplant recipients
Authors: Olyaei, AJ deMattos, AM Bennett, WM
Citation: Aj. Olyaei et al., A practical guide to the management of hypertension in renal transplant recipients, DRUGS, 58(6), 1999, pp. 1011-1027
Vancomycin-resistant Enterococcus in liver transplant patients
Authors: Orloff, SL Busch, AMH Olyaei, AJ Corless, CL Benner, KG Flora, KD Rosen, HR Rabkin, JM
Citation: Sl. Orloff et al., Vancomycin-resistant Enterococcus in liver transplant patients, AM J SURG, 177(5), 1999, pp. 418-422
Distant processing of pancreas islets for autotransplantation following total pancreatectomy
Authors: Rabkin, JM Olyaei, AJ Orloff, SL Geisler, SM Wahoff, DC Hering, BJ Sutherland, DER
Citation: Jm. Rabkin et al., Distant processing of pancreas islets for autotransplantation following total pancreatectomy, AM J SURG, 177(5), 1999, pp. 423-427
Risultati: 1-13 |